Pay in 4 interest-free payments of $7.21 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
From available case reports, compounding pharmacy data, and practitioner experience, the following have been observed: BPC-157 Reported Side Effects Nausea and gastrointestinal discomfort (especially with oral administration) Dizziness or light-headedness Flushing or warmth at injection sites Headache Fatigue or somnolence in some users TB-500 Reported Side Effects Injection site reactions (redness, mild pain, swelling) Transient fatigue or lethargy following administration Headache Possible flu-like symptoms in a minority of users Critical Risk Note: Because neither peptide has undergone full clinical trial evaluation in humans, the complete adverse event profile is unknown
Provincial and Territorial Public Drug Benefit Programs Health Canada Federal directory of each province and territory's public drug benefit plan, used to verify how provincial coverage rules and dispensing-fee structures vary across Canada.
What factors influenced retatrutide dosing outcomes
For Mounjaro: confirmed type 2 diabetes diagnosis, recent HbA1c, current medication list, documentation of metformin trial (unless contraindicated), and the planned dosing schedule
US$ 21.61
US$ 23.22
US$ 20.13
US$ 22.77
